ANTICANCER, INC.
Patient-derived orthotopic xenograft (PDOX) mouse models of soft tissue sarcoma for drug testing and therapy development
- Sector
- Biotech
- Total capital
- $449K
- Federal grants
- $449K
- 2 awards · 2016
- Rank in peer group#15 of 26
- Private capital raised
- None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 4
- 25 pending · first 2016
- Rank in peer group#2 of 26
Capital timeline
Latest events
- Federal grantHealth and Human S · Phase I · Establishment of a patient like mouse models of soft tissue sarcoma sub types$225K
- Federal grantHealth and Human S · Phase I · Establishment of a patient-like mouse models of soft-tissue sarcoma sub-types$225K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 26 peers
Line = medianBiotech · Instrument
- Federal grantsBelow median
- Granted patents#2 · top 8%
- Linked publications#1 · top 4%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
No founders are linked to this company yet.
Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.
Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026
Claim this profile to add your teamWhat it has protected
USPTO · 4 granted of 29- PendingRecombinant Methioninase In The Treatment Of CancerUSPTOApplication 19097356
- PendingMethod And Composition For The Treatment Of CancerUSPTOApplication 18482386
- GrantedTransplantation Method To Increase The Establishment Rate Of Human Tumors In Immunodeficient MiceUSPTOUS 11,871,731
Show all 29 patent records
- Recombinant Methioninase In The Treatment Of CancerOct 2, 2025 · Application 19097356Pending
- Method And Composition For The Treatment Of CancerApr 11, 2024 · Application 18482386Pending
- Transplantation Method To Increase The Establishment Rate Of Human Tumors In Immunodeficient MiceJan 16, 2024 · US 11,871,731Granted
- Orally Administered Composition to Lower Serum Methionine Levels and Method of UseMay 11, 2021 · US 11,001,826Granted
- Methods To Determine Cancer Treatment Using Robotic High-throughput Drug Sensitivity TestingJan 10, 2019 · Application 16029189Pending
- Methods To Enhance Tumor-targeting By BacteriaAug 23, 2018 · Application 15902769Pending
- Individualized Bacterial Treatment Of Pancreatic CancerJan 10, 2017 · US 9,539,290Granted
- Schiff-base Conjugate Of N, N-dibutyl-p-phenylenediamine With Pyridoxal 5'-PHOSPHATE For Improved Homocysteine Assays Using Pyridoxal 5'-PHOSPHATE-DEPENDENT EnzymesDec 29, 2016 · Application 15261249Pending
- Schiff-base Conjugate Of N, N-dibutyl-p-phenylenediamine With Pyridoxal 5'-PHOSPHATE For Improved Homocysteine Assays Using Pyridoxal 5'-PHOSPHATE-DEPENDENT EnzymesOct 11, 2016 · US 9,464,312Granted
- Individualized Bacterial Treatment Of Pancreatic CancerJun 30, 2016 · Application 15059586Pending
- USE OF PLP WITH PEG-rMETase IN VIVO FOR ENHANCED EFFICACYJul 24, 2014 · Application 14162655Pending
- Portable Digital Imaging System For Fluorescence-guided SurgeryJun 26, 2014 · Application 14140333Pending
- Methods For Increasing Protein Polyethylene Glycol (peg) ConjugationSep 26, 2013 · Application 13899225Pending
- Imageable Animal Model Of Sars InfectionApplication PCTUS2004016976Pending
- Pancreatic Cancer TreatmentApplication PCTUS2004015997Pending
- Immunocompromised Rodents As Dual Color Tumor ModelsApplication PCTUS2004003636Pending
- Total Cysteine AssayApplication PCTUS2002037420Pending
- Oral formulation of recombinant methioninase for cancer treatment, prevention and anti-agingApplication 62574693Pending
- Imageable Patient Tumors In MiceApplication PCTUS2012072134Pending
- Imageable Rodent Model Of AsthmaApplication PCTUS2008078506Pending
- Rapid In Vivo Model For AngiogenesisApplication PCTUS2007079753Pending
- Cancer Selective AuxotrophsApplication PCTUS2005023454Pending
- Methods For Increasing Protein Polyethylene Glycol (peg) ConjugationApplication PCTUS2005008267Pending
- Whole Body Imaging Using Portable Observation SystemsApplication PCTUS2005003001Pending
- Enzymatic Methionine AssayApplication PCTUS2005002293Pending
- Modular System For Multi-color, Whole Body Fluorescence ImagingApplication PCTUS2004040787Pending
- Angiogensis Models Using Nestin-expressing Stem Cells To Image Nascent Blood VesselsApplication PCTUS2004036105Pending
- The Use Of Plp With Peg-rmetase In Vivo For Enhanced EfficacyApplication PCTUS2004022769Pending
- Lyase Treatment For P. CariniiApplication PCTUS2004019989Pending
Recent research by its founders
- A new locoregional mouse model of gastric cancer for identifying probes for fluorescence guided surgery20255 cites
- Mucin4 (MUC4) Antibody Labeled with an NIR Dye Brightly Targets Pancreatic Cancer Liver Metastases and Peritoneal Carcinomatosis20253 cites
- Prostate Cancer Patient With Lymph-node Metastasis Treated Only With Methionine Restriction Has Stable Disease for Two Years Demonstrated With PET/CT and PSMA-PET Scanning and PSA Testing20253 cites
Related companies, and why
- NEUROP, INC.Similar federal contract value in Biotech · null in contracts
- Axiom Therapeutics Inc.Similar federal contract value in Biotech · null in contracts
- FluidForm Bio, Inc.Similar federal contract value in Biotech · null in contracts
- PHARMATROPHIX INCSimilar federal contract value in Biotech · null in contracts
- Nanotools BioscienceSimilar federal contract value in Biotech · null in contracts
- VilyaSimilar federal contract value in Biotech · null in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .